Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Return on Sales (2022 - 2025)

Historic Return on Sales for Cardio Diagnostics Holdings (CDIO) over the last 4 years, with Q3 2025 value amounting to 600.54%.

  • Cardio Diagnostics Holdings' Return on Sales fell 3858600.0% to 600.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 415.16%, marking a year-over-year decrease of 1839100.0%. This contributed to the annual value of 240.28% for FY2024, which is 2506000.0% up from last year.
  • According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Return on Sales is 600.54%, which was down 3858600.0% from 225.18% recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Return on Sales registered a high of 163.66% during Q2 2024, and its lowest value of 5687.95% during Q1 2023.
  • For the 4-year period, Cardio Diagnostics Holdings' Return on Sales averaged around 1209.93%, with its median value being 299.15% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 54265400bps in 2024, then tumbled by -14780300bps in 2025.
  • Over the past 4 years, Cardio Diagnostics Holdings' Return on Sales (Quarter) stood at 2503.22% in 2022, then surged by 90bps to 261.57% in 2023, then dropped by -29bps to 336.73% in 2024, then plummeted by -78bps to 600.54% in 2025.
  • Its Return on Sales stands at 600.54% for Q3 2025, versus 225.18% for Q2 2025 and 1739.43% for Q1 2025.